ZA200801813B - Crystalline salts of 7-[4-(4-naphthalen-1-yl-piperazin-1-yl)-butoxy]-3,4-dihydro-1H-(1,8)naphthyridin-2-one - Google Patents

Crystalline salts of 7-[4-(4-naphthalen-1-yl-piperazin-1-yl)-butoxy]-3,4-dihydro-1H-(1,8)naphthyridin-2-one

Info

Publication number
ZA200801813B
ZA200801813B ZA200801813A ZA200801813A ZA200801813B ZA 200801813 B ZA200801813 B ZA 200801813B ZA 200801813 A ZA200801813 A ZA 200801813A ZA 200801813 A ZA200801813 A ZA 200801813A ZA 200801813 B ZA200801813 B ZA 200801813B
Authority
ZA
South Africa
Prior art keywords
naphthyridin
naphthalen
piperazin
butoxy
dihydro
Prior art date
Application number
ZA200801813A
Other languages
English (en)
Inventor
Beylin Vladimir Genukh
Yahyai Nahid
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ZA200801813B publication Critical patent/ZA200801813B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA200801813A 2005-10-31 2008-02-26 Crystalline salts of 7-[4-(4-naphthalen-1-yl-piperazin-1-yl)-butoxy]-3,4-dihydro-1H-(1,8)naphthyridin-2-one ZA200801813B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73191905P 2005-10-31 2005-10-31

Publications (1)

Publication Number Publication Date
ZA200801813B true ZA200801813B (en) 2009-08-26

Family

ID=37943848

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200801813A ZA200801813B (en) 2005-10-31 2008-02-26 Crystalline salts of 7-[4-(4-naphthalen-1-yl-piperazin-1-yl)-butoxy]-3,4-dihydro-1H-(1,8)naphthyridin-2-one

Country Status (14)

Country Link
US (1) US20080269242A1 (zh)
EP (1) EP1945638A2 (zh)
JP (1) JP2007126456A (zh)
KR (1) KR20080053398A (zh)
CN (1) CN101300256A (zh)
AR (1) AR056743A1 (zh)
AU (1) AU2006310283A1 (zh)
BR (1) BRPI0618276A2 (zh)
CA (1) CA2627779A1 (zh)
IL (1) IL189879A0 (zh)
RU (1) RU2008109958A (zh)
TW (1) TW200804373A (zh)
WO (1) WO2007052104A2 (zh)
ZA (1) ZA200801813B (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2445502T (pt) 2009-06-25 2017-09-22 Alkermes Pharma Ireland Ltd Compostos heterocíclicos para o tratamento de distúrbios neurológicos e psicológicos
NZ748572A (en) 2012-09-19 2020-07-31 Alkermes Pharma Ireland Ltd Pharmaceutical compositions having improved storage stability
AU2015231278B2 (en) 2014-03-20 2020-01-23 Alkermes Pharma Ireland Limited Aripiprazole formulations having increased injection speeds
AU2019230014A1 (en) 2018-03-05 2020-09-17 Alkermes Pharma Ireland Limited Aripiprazole dosing strategy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7160888B2 (en) * 2003-08-22 2007-01-09 Warner Lambert Company Llc [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia

Also Published As

Publication number Publication date
AU2006310283A1 (en) 2007-05-10
IL189879A0 (en) 2008-11-03
BRPI0618276A2 (pt) 2011-08-23
WO2007052104A3 (en) 2007-08-02
TW200804373A (en) 2008-01-16
CA2627779A1 (en) 2007-05-10
JP2007126456A (ja) 2007-05-24
US20080269242A1 (en) 2008-10-30
EP1945638A2 (en) 2008-07-23
WO2007052104A2 (en) 2007-05-10
CN101300256A (zh) 2008-11-05
RU2008109958A (ru) 2009-12-10
KR20080053398A (ko) 2008-06-12
AR056743A1 (es) 2007-10-24
WO2007052104A8 (en) 2008-05-15

Similar Documents

Publication Publication Date Title
IL192242A0 (en) Improved process for the preparation of the salts of 4-(benzimidazolylmethylamino)-benzamides
HK1158627A1 (en) 1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-)aryl substituted 1-h- pyrrole derivatives as acid secretion inhibitors
IL208963A0 (en) Substituted quinoline compounds
AP2321A (en) Quinoline derivatives for use as mycobactrial inhibitor.
ZA200804489B (en) 1-orthofluorophenyl substituted 1, 2, 5-thiazolidinedione derivatives as PTP-AS inhibitors
ZA200801890B (en) Novel crystalline form of a pyridazino (4, 5-B) indole derivative
TW200600097A (en) Stable crystal of 4-oxoquinoline compound technical field of the invention
SI1883451T1 (sl) Substituirane indolne spojine z NOS inhibitorno aktivnostjo
IL192241A0 (en) Improved process for the preparation of 4-(benzimidazolylmethylamino)-benzamides and the salts thereof
IL192227A0 (en) Amorphous form of 1,2-dihydropyridine compound
ZA200507344B (en) Novel crystalline modification of the anhydrate of boscalid
EP1870401A4 (en) SUBSTITUTE DERIVATIVE PIPERAZINE IN 1,4
WO2007062308A3 (en) Homo- and heterocyclic compounds suitable as cetp inhibitors
ZA200800783B (en) Antibacterial quinoline derivatives
ZA200801813B (en) Crystalline salts of 7-[4-(4-naphthalen-1-yl-piperazin-1-yl)-butoxy]-3,4-dihydro-1H-(1,8)naphthyridin-2-one
WO2007146115A3 (en) 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline hydrochloric acid salts
ZA200805348B (en) ITQ-26, new crystalline microporous material
PL372356A1 (pl) Nowe związki, pochodne kwasu 3-fenylopropionowego
EP1858844A4 (en) NEW CRYSTALLINE FORMS OF ANTIDIABETIC COMPOUNDS
IL186221A0 (en) Crystalline rosuvastatin intermediate
GB0506967D0 (en) Novel crystalline salt
PL2029569T3 (pl) Sposób wytwarzania dispiro-1,2,4-trioksolanowych środków przeciwmalarycznych (SOLE OZ277)
GB0519969D0 (en) Quinoline compounds
ZA200804193B (en) 4-heteroarymethyl substituted phthalazinone derivatives
ZA200702193B (en) 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds